Myeloid differentiation factor 88

Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues

J. Zhu, Li, Q., He, J., and Ma, K., Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues, vol. 14, pp. 14239-14245, 2015.

We studied the expression level of myeloid differentiation factor 88 (MyD88) in non-small cell lung carcinoma (NSCLC) and normal paracancerous tissues, to determine its relationship with clinical pathological characteristics and prognosis. In total, 82 NSCLC patients who had received surgical treatment in our hospital between September 2008 and December 2013 were selected for this study. Another 82 normal paracancerous lung tissue samples were used as controls. All patients had complete clinical records, and they were followed-up for 5 years.

Subscribe to Myeloid differentiation factor 88